Cargando…

Induction of Influenza (H5N8) Antibodies by Modified Vaccinia Virus Ankara H5N1 Vaccine

Detalles Bibliográficos
Autores principales:	de Vries, Rory D., De Gruyter, Heidi L.M., Bestebroer, Theo M., Pronk, Mark, Fouchier, Ron A.M., Osterhaus, Albert D.M.E., Sutter, Gerd, Kreijtz, Joost H.C.M., Rimmelzwaan, Guus F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Centers for Disease Control and Prevention 2015
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4451911/ https://www.ncbi.nlm.nih.gov/pubmed/25988813 http://dx.doi.org/10.3201/eid2106.150021

Ejemplares similares

Modified Vaccinia Virus Ankara (MVA) as Production Platform for Vaccines against Influenza and Other Viral Respiratory Diseases
por: Altenburg, Arwen F., et al.
Publicado: (2014)

MVA-Based H5N1 Vaccine Affords Cross-Clade Protection in Mice against Influenza A/H5N1 Viruses at Low Doses and after Single Immunization
por: Kreijtz, Joost H. C. M., et al.
Publicado: (2009)

Possible Increased Pathogenicity of Pandemic (H1N1) 2009 Influenza Virus upon Reassortment
por: Schrauwen, Eefje J.A., et al.
Publicado: (2011)

Reassortment between Avian H5N1 and Human Influenza Viruses Is Mainly Restricted to the Matrix and Neuraminidase Gene Segments
por: Schrauwen, Eefje J. A., et al.
Publicado: (2013)

Modified Vaccinia Virus Ankara Preferentially Targets Antigen Presenting Cells In Vitro, Ex Vivo and In Vivo
por: Altenburg, Arwen F., et al.
Publicado: (2017)

Vaccination against Human Influenza A/H3N2 Virus Prevents the Induction of Heterosubtypic Immunity against Lethal Infection with Avian Influenza A/H5N1 Virus
por: Bodewes, Rogier, et al.
Publicado: (2009)

Wild Ducks as Long-Distance Vectors of Highly Pathogenic Avian Influenza Virus (H5N1)
por: Keawcharoen, Juthatip, et al.
Publicado: (2008)

Recombinant Modified Vaccinia Virus Ankara Expressing a Glycosylation Mutant of Dengue Virus NS1 Induces Specific Antibody and T-Cell Responses in Mice
por: Wilken, Lucas, et al.
Publicado: (2023)

Low Virulence and Lack of Airborne Transmission of the Dutch Highly Pathogenic Avian Influenza Virus H5N8 in Ferrets
por: Richard, Mathilde, et al.
Publicado: (2015)

A recombinant Modified Vaccinia virus Ankara expressing prME of tick-borne encephalitis virus affords mice full protection against TBEV infection
por: Kubinski, Mareike, et al.
Publicado: (2023)

Effects of pre-existing orthopoxvirus-specific immunity on the performance of Modified Vaccinia virus Ankara-based influenza vaccines
por: Altenburg, Arwen F., et al.
Publicado: (2018)

Highly Pathogenic Avian Influenza Virus (H5N1) Infection in Red Foxes Fed Infected Bird Carcasses
por: Reperant, Leslie A., et al.
Publicado: (2008)

Age distribution of cases caused by different influenza viruses
por: Rimmelzwaan, Guus F, et al.
Publicado: (2013)

A vital gene for modified vaccinia virus Ankara replication in human cells
por: Sutter, Gerd
Publicado: (2020)

The Future of Research and Publication on Altered H5N1 Viruses
por: Herfst, Sander, et al.
Publicado: (2012)

Limited airborne transmission of influenza A/H7N9 virus between ferrets
por: Richard, Mathilde, et al.
Publicado: (2013)

Avian Influenza H5N1 in Tigers and Leopards
por: Keawcharoen, Juthatip, et al.
Publicado: (2004)

Matrix-M™ adjuvant enhances immunogenicity of both protein- and modified vaccinia virus Ankara-based influenza vaccines in mice
por: Magnusson, Sofia E., et al.
Publicado: (2018)

Modified Vaccinia virus Ankara but not vaccinia virus induces chemokine expression in cells of the monocyte/macrophage lineage
por: Lehmann, Michael H, et al.
Publicado: (2015)

Vectors Based on Modified Vaccinia Ankara Expressing Influenza H5N1 Hemagglutinin Induce Substantial Cross-Clade Protective Immunity
por: Hessel, Annett, et al.
Publicado: (2011)

Market implementation of the MVA platform for pre-pandemic and pandemic influenza vaccines: A quantitative key opinion leader analysis
por: Ramezanpour, Bahar, et al.
Publicado: (2015)

Progress toward a Universal H5N1 Vaccine: A Recombinant Modified Vaccinia Virus Ankara-Expressing Trivalent Hemagglutinin Vaccine
por: Prabakaran, Mookkan, et al.
Publicado: (2014)

Non-plaque-forming virions of Modified Vaccinia virus Ankara express viral genes
por: Lülf, Anna-Theresa, et al.
Publicado: (2016)

Antigenic Variation of Clade 2.1 H5N1 Virus Is Determined by a Few Amino Acid Substitutions Immediately Adjacent to the Receptor Binding Site
por: Koel, Björn F., et al.
Publicado: (2014)

Avian Influenza A(H10N7) Virus–Associated Mass Deaths among Harbor Seals
por: Bodewes, Rogier, et al.
Publicado: (2015)

Modified vaccinia virus Ankara as antigen delivery system: how can we best use its potential?
por: Drexler, Ingo, et al.
Publicado: (2004)

Towards universal influenza vaccines?
por: Osterhaus, Ab, et al.
Publicado: (2011)

Genetic Characterization of HPAI (H5N1) Viruses from Poultry and Wild Vultures, Burkina Faso
por: Ducatez, Mariette F., et al.
Publicado: (2007)

Tracking Modified Vaccinia Virus Ankara in the Chicken Embryo: In Vivo Tropism and Pathogenesis of Egg Infections
por: Langenmayer, Martin C., et al.
Publicado: (2018)

Correction for Koel et al., Antigenic Variation of Clade 2.1 H5N1 Virus Is Determined by a Few Amino Acid Substitutions Immediately Adjacent to the Receptor Binding Site
por: Koel, Björn F., et al.
Publicado: (2014)

Targets for the Induction of Protective Immunity Against Influenza A Viruses
por: Bodewes, Rogier, et al.
Publicado: (2010)

Serological Evidence for Non-Lethal Exposures of Mongolian Wild Birds to Highly Pathogenic Avian Influenza H5N1 Virus
por: Gilbert, Martin, et al.
Publicado: (2014)

Immunogenicity of modified vaccinia virus Ankara expressing the hemagglutinin stalk domain of pandemic (H1N1) 2009 influenza virus
por: Di Mario, Giuseppina, et al.
Publicado: (2017)

Vaccination with recombinant modified vaccinia virus Ankara prevents the onset of intestinal allergy in mice
por: Bohnen, C, et al.
Publicado: (2013)

Wild Birds and Increased Transmission of Highly Pathogenic Avian Influenza (H5N1) among Poultry, Thailand
por: Keawcharoen, Juthatip, et al.
Publicado: (2011)

Recombinant Modified Vaccinia Virus Ankara Expressing Glycoprotein E2 of Chikungunya Virus Protects AG129 Mice against Lethal Challenge
por: van den Doel, Petra, et al.
Publicado: (2014)

Advances in influenza vaccination
por: Reperant, Leslie A., et al.
Publicado: (2014)

Influenza A(H1N1) Oseltamivir Resistant Viruses in the Netherlands During the Winter 2007/2008
por: Dijkstra, Frederika, et al.
Publicado: (2011)

Modified Vaccinia Virus Ankara: History, Value in Basic Research, and Current Perspectives for Vaccine Development
por: Volz, A., et al.
Publicado: (2017)

A modified vaccinia Ankara vaccine vector expressing a mosaic H5 hemagglutinin reduces viral shedding in rhesus macaques
por: Florek, Kelsey R., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_i4lmme6igv0mrr3h6rb2me2hhb